Elequin Capital’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-34,464
Closed -$496K 385
2025
Q1
$496K Buy
34,464
+23,751
+222% +$363K 0.06% 74
2024
Q4
$162K Buy
+10,713
New +$172K 0.01% 88
2024
Q1
Sell
-5,229
Closed -$78.2K 262
2023
Q4
$78.2K Sell
5,229
-12,684
-71% -$184K 0.02% 191
2023
Q3
$260K Buy
+17,913
New +$268K 0.05% 92
2023
Q2
Sell
-224
Closed -$3.39K 542
2023
Q1
$3.39K Sell
224
-77,248
-100% -$1.14M ﹤0.01% 240
2022
Q4
$1.07M Buy
+77,472
New +$1.09M 0.3% 44

Other funds holding BCAT

Elequin Capital's BCAT Position: Q2 2025 in Review

Elequin Capital sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2025, closing a stake of 34,464 shares — an estimated $496K sold.

Elequin Capital first reported a position in BCAT in Q4 2022 and held it in 6 quarters. The position peaked at $1.07M in Q4 2022. 91 funds tracked by Wall St. Rank hold BCAT as of Q2 2025.

  • Elequin Capital reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2025 after selling out during the quarter.
  • Elequin Capital sold 34,464 BlackRock Capital Allocation Term Trust shares in Q2 2025, an estimated $496K.
  • Elequin Capital first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and held it in 6 quarters.
  • Elequin Capital's BlackRock Capital Allocation Term Trust position peaked at $1.07M in Q4 2022.
  • 91 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2025.

Based on Elequin Capital's 13F filing for Q2 2025, filed 11 Aug 2025.